* CARMAT *
2008 - IDF
Vélizy
(near Paris)
www.carmatsas.com Development, Device
Key words: Artificial heart, Computer simulation, Electronic captors, Bioprothesis
Mission: to clinically develop, then market a fully implantable artificial heart for patients suffering in the aftermath of a massive heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible
Clients: Hospitals
contact@carmatsas.com
Age: 3 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Spin-off |
Managing Dir.-CEO: Conviti (Marcello) [born 1952, Ph.D., MBA, ex-Edwards Lifesciences, Sorin]
Sc.Dir.-CSO: Carpentier (Alain) [born 1933, co-founder, M.D. (surgery), Hospital Professor]
Fin.Dir.-CFO:
MktgComm: Leroy (Valérie) [Ms. Mktg (Paris), ex-Toshiba Systèmes, Medtronic, Edwards Lifesciences]
BusDev:
Financers (Hist.): Truffle Capital, Oseo, EADS
Note : company first sourced as a J.V. Carpentier-Matra, in 1993 (company name, Carmat = Carpentier + Matra)
Note : Internet showroom, available since June 2009 | Turnover (M€) : n.a.
Total funding (M€) : 52.8
Last funding (M€) : 29.3
Focus : Cardiovasc
Position : Preclin
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2011 .08 | Public offering : 29.3 M€ (existing shareholders with preferred rights, oversubscribed at 127.4%) | PBO | [3 years] |
| 2010 .11 | Research : assembly of the first clinical version of its artificial heart (clinical trial scheduled in 2011) | R&D | [2 years] |
| 2010 .07 | Listing on Alternext Paris : 16.0 M€ | PBO | [2 years] |
| 2009 .10 | Production : inauguration of cleanroom facilities in Vélizy | INDUS | [1 year] |
| 2009 .09 | Nomination : Marcello Conviti, new CEO, replacing Patrick Coulombier (COO) | ORGN | [1 year] |
| 2009 .06 | Financing (no interest loan) : 33.0 M€, by OSEO Innovation, to support 5 year-development plans | DEBT | [1 year] |
| 2009 .05 | Company move from Suresnes to Vélizy (both, near Paris) | ORGL | [0 year] |
| 2008 .11 | 1st round-financing : 7.5 M€, by Truffle Capital, EADS, and Prof. Carpentier's foundation | RFINA | [0 year] |
| 2008 .10 | Company founded by Alain Carpentier, with financial support by Oseo, based on a long collaboration between the renowned surgeon and EADS on implementation of biomaterials and cutting-edge technologies in the construction of an artificial heart | ORGF | [0 year] | Actualisation / Updating: 22-Sep-2011 |
|
